Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
2.05
0.02 (0.99%)
At close: Oct 03, 2025, 3:59 PM
2.05
0.00%
After-hours: Oct 03, 2025, 04:10 PM EDT
0.99% (1D)
| Bid | 1.95 |
| Market Cap | 115.36M |
| Revenue (ttm) | 40.5M |
| Net Income (ttm) | -54.47M |
| EPS (ttm) | -0.98 |
| PE Ratio (ttm) | -2.09 |
| Forward PE | -50.75 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 2.13 |
| Volume | 379,977 |
| Avg. Volume (20D) | 592,607 |
| Open | 2.01 |
| Previous Close | 2.03 |
| Day's Range | 2.00 - 2.08 |
| 52-Week Range | 0.51 - 3.22 |
| Beta | 1.47 |
| Ex-Dividend Date | n/a |
About SPRO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SPRO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SPRO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-17.8%
Spero Therapeutics shares are trading lower follow...
Unlock content with
Pro Subscription
2 months ago
-1.36%
Shares of several biotechnology stocks are trading higher amid Vinay Prasad's departure as director of the FDA's Center for Biologics Evaluation and Research.
